Oxybutynin reduces sweating in depressed patients treated with sertraline: a double-blind, placebo-controlled, clinical study

BACKGROUND: Selective serotonin reuptake inhibitors are primarily used in the pharmacological treatment of patients experiencing a major depressive disorder. However, one of the common unwanted effects is excessive sweating or hyperhidrosis. Oxybutynin is an anticholinergic medication which reduces...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghaleiha, Ali, Jahangard, Leila, Sherafat, Zahra, Ahmadpanah, Mohammad, Brand, Serge, Holsboer-Trachsler, Edith, Bajoghli, Hafez, Haghighi, Mohammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3446858/
https://www.ncbi.nlm.nih.gov/pubmed/23028229
http://dx.doi.org/10.2147/NDT.S36329

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3446858/
https://www.ncbi.nlm.nih.gov/pubmed/23028229
http://dx.doi.org/10.2147/NDT.S36329

Ejemplares similares